Table 2

Distribution of iNOS scores of tumor cells (iNOS-T), tumor-associated stromal fibroblasts (iNOS-F), and endothelial cells (iNOS-E) according to clinicopathologic parameters in cases with gastric carcinoma
Variables iNOS Score [Mean ± SD (Min.-Max.)]
iNOS-T iNOS-F iNOS-E
Histological type
NOS/tubular/papillary 2.6 ± 2.3 (0–6) 4.8 ± 1.7 (2–8) 5.9 ± 2.1 (2–8)
Mucinous/poorly cohesive 4.8 ± 2.2 (2–8) 4.4 ± 1.9 (2–7) 5.9 ± 2.7 (2–8)
Differentiation
Well/moderate 2.6 ± 2.3 (0–6) 4.6 ± 2.2 (0–8) 5.6 ± 2.8 (2–8)
Poorly/signet ring cell 4.8 ± 2.2 (2–8) 4.3 ± 1.3 (0–8) 6.0 ± 1.6 (2–8)
pN
N0 1.3 ± 1.8 (0–5) 2.9 ± 1.3 (2–5) 3.2 ± 1.9 (2–7)
N1 4.1 ± 1.3 (2–6) 5.9 ± 1.6 (4–8) 6.7 ± 1.7 (4–8)
N2 4.1 ± 1.9 (2–8) 4.9 ± 1.2 (3–7) 6.6 ± 1.3 (4–8)
N3 5.9 ± 2.2 (2–8) 5.2 ± 1.2 (3–7) 6.6 ± 1.1 (4–8)
pT
T1 1.5 ± 1.1 (0–7) 2.4 ± 1.2 (2–7) 3.1 ± 1.7 (2–7)
T2 4.2 ± 1.5 (2–6) 5.4 ± 1.7 (4–8) 6.8 ± 1.8 (4–8)
T3 4.4 ± 1.9 (2–8) 4.9 ± 1.5 (3–7) 6.2 ± 1.7 (4–8)
T4 5.9 ± 2.1 (2–8) 5.1 ± 1.4 (3–7) 6.9 ± 1.2 (4–8)
TNM stage
I 0.0 ± 0.0 (0–0) 3.3 ± 1.5 (2–5) 4.0 ± 2.6 (2–7)
II 3.2 ± 1.8 (0–6) 4.4 ± 1.9 (2–8) 5.0 ± 2.4 (2–8)
III 5.4 ± 3.2 (2–8) 5.3 ± 1.3 (3–7) 6.8 ± 1.0 (4–8)
IV - - -
Total 4.0 ± 2.5 (0–8) 4.0 ± 2.5 (0–8) 5.9 ± 2.0 (2–8)

Karadayı et al.

Karadayı et al. Diagnostic Pathology 2013 8:151   doi:10.1186/1746-1596-8-151

Open Data